Home
Home

'term-id:[833]'

Arena, Eisai Weight-Loss Drug Unlikely to Cause Brain Tumors, Study Finds

Arena, Eisai Weight-Loss Drug Unlikely to Cause Brain Tumors, Study Finds
Bloomberg

FDA Bullies Obesity Drugmakers

FDA Bullies Obesity Drugmakers
Motley Fool

Arena's New Data Doesn't Change Obesity Pill Outlook

Arena's New Data Doesn't Change Obesity Pill Outlook
Investopedia

Don't Believe the Obesity Hype

Don't Believe the Obesity Hype
Motley Fool

Arena, Orexigen and Vivus: An Update on Their Obesity Drugs

Arena, Orexigen and Vivus: An Update on Their Obesity Drugs
Seeking Alpha

Arena shares rise on analysis of obesity drug data

Arena shares rise on analysis of obesity drug data
Yahoo/AP

News

Arena Pharmaceuticals: A Nail Biting Time for Lorcaserin Approval
Seeking Alpha

News

Oops! Arena’s CEO Neglects to Mention Diet Drug Causes Cancer in Rats
BNET Pharma

News

Arena's Obese To-Do List
Motley Fool

News

Arena Fires 25% of Workforce After Diet Drug Delay
Bloomberg